
// Phenotype library name
phenotype "Clinical Trial Criteria related to B-cell acute lymphoblastic leukemia Ph-positive" version "1";

// Phenotype library description 
description "Generated query for cancer treatment based on https://hemonc.org/wiki/Main_Page";

// # Referenced libraries #
include ClarityCore version "1.0" called Clarity;

documentset Docs:
    Clarity.createReportTypeList(["Clinical Trial Inclusion Criteria", "Clinical Trial Exclusion Criteria"]);

// Cancers

termset Condition_Terms_b_cell_acute_lymphoblastic_leukemia_ph_positive:[
    "b-cell acute lymphoblastic leukemia ph-positive"
];

define final Condition_b_cell_acute_lymphoblastic_leukemia_ph_positive:
  Clarity.ProviderAssertion({
    termset:[Condition_Terms_b_cell_acute_lymphoblastic_leukemia_ph_positive],
    documentset:[Docs]
   }); 


// Regimen names

termset Regimen_Terms_Dasatinib_Prednisone:[
    "Dasatinib & Prednisone"
];

define   Regimen_Dasatinib_Prednisone:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Dasatinib_Prednisone],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Daunorubicin_L_Asparaginase_Vincristine_Prednisone_Imatinib:[
    "Daunorubicin, L-Asparaginase, Vincristine, Prednisone, Imatinib"
];

define   Regimen_Daunorubicin_L_Asparaginase_Vincristine_Prednisone_Imatinib:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Daunorubicin_L_Asparaginase_Vincristine_Prednisone_Imatinib],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Daunorubicin_Vincristine_Prednisolone_Nilotinib:[
    "Daunorubicin, Vincristine, Prednisolone, Nilotinib"
];

define   Regimen_Daunorubicin_Vincristine_Prednisolone_Nilotinib:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Daunorubicin_Vincristine_Prednisolone_Nilotinib],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Hyper_CVAD_Dasatinib:[
    "Hyper-CVAD & Dasatinib"
];

define   Regimen_Hyper_CVAD_Dasatinib:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Hyper_CVAD_Dasatinib],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Hyper_CVAD_Imatinib:[
    "Hyper-CVAD & Imatinib"
];

define   Regimen_Hyper_CVAD_Imatinib:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Hyper_CVAD_Imatinib],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Imatinib_Prednisone:[
    "Imatinib & Prednisone"
];

define   Regimen_Imatinib_Prednisone:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Imatinib_Prednisone],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Imatinib_Vincristine_Dexamethasone:[
    "Imatinib, Vincristine, Dexamethasone"
];

define   Regimen_Imatinib_Vincristine_Dexamethasone:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Imatinib_Vincristine_Dexamethasone],
    documentset:[Docs]
   }); 


termset Regimen_Terms_HAM_Imatinib:[
    "HAM  and  Imatinib", "HAM & Imatinib", "HAM + Imatinib", "HAM / Imatinib", "HAM and Imatinib", "HAM+Imatinib", "HAM/Imatinib"
];

define   Regimen_HAM_Imatinib:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_HAM_Imatinib],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Cytarabine_Idarubicin_Imatinib:[
    "Cytarabine, Idarubicin, Imatinib"
];

define   Regimen_Cytarabine_Idarubicin_Imatinib:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Cytarabine_Idarubicin_Imatinib],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Dasatinib_monotherapy:[
    "Dasatinib monotherapy"
];

define   Regimen_Dasatinib_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Dasatinib_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Dasatinib_Vincristine_Prednisone:[
    "Dasatinib, Vincristine, Prednisone"
];

define   Regimen_Dasatinib_Vincristine_Prednisone:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Dasatinib_Vincristine_Prednisone],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Nilotinib_monotherapy:[
    "Nilotinib monotherapy"
];

define   Regimen_Nilotinib_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Nilotinib_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Bosutinib_monotherapy:[
    "Bosutinib monotherapy"
];

define   Regimen_Bosutinib_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Bosutinib_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Imatinib_monotherapy:[
    "Imatinib monotherapy"
];

define   Regimen_Imatinib_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Imatinib_monotherapy],
    documentset:[Docs]
   }); 


termset Regimen_Terms_Ponatinib_monotherapy:[
    "Ponatinib monotherapy"
];

define   Regimen_Ponatinib_monotherapy:
  Clarity.ProviderAssertion({
    termset:[Regimen_Terms_Ponatinib_monotherapy],
    documentset:[Docs]
   }); 



// Results

        
define final CancerRegimen_b_cell_acute_lymphoblastic_leukemia_ph_positive:
    where Dasatinib_Prednisone_Regimen OR Daunorubicin_L_Asparaginase_Vincristine_Prednisone_Imatinib_Regimen OR Daunorubicin_Vincristine_Prednisolone_Nilotinib_Regimen OR Hyper_CVAD_Dasatinib_Regimen OR Hyper_CVAD_Imatinib_Regimen OR Imatinib_Prednisone_Regimen OR Imatinib_Vincristine_Dexamethasone_Regimen OR HAM_Imatinib_Regimen OR Cytarabine_Idarubicin_Imatinib_Regimen OR Dasatinib_monotherapy_Regimen OR Dasatinib_Vincristine_Prednisone_Regimen OR Nilotinib_monotherapy_Regimen OR Bosutinib_monotherapy_Regimen OR Imatinib_monotherapy_Regimen OR Ponatinib_monotherapy_Regimen;
          
define final MatchedAllResults:
    where CancerRegimen_b_cell_acute_lymphoblastic_leukemia_ph_positive AND b_cell_acute_lymphoblastic_leukemia_ph_positive_Condition;
        
        

// Comments
/***

***/

